Advanced Medical Solutions Grp PLC
05 September 2006
For Immediate Release 5 September 2006
Advanced Medical Solutions Group plc
('AMS' or 'the Company')
Director Share Purchases
The Company was informed on 5th September 2006 that, on that day, Geoffrey
Vernon (Non-Executive Chairman), Don Evans (Chief Executive), Mary Tavener
(Finance Director), Stephen Harris (Non-Executive Director) and Chris Meredith
(Commercial Director) all acquired ordinary shares of 5p each in the Company
('Ordinary Shares') at a price of 11.5 pence per Ordinary Share. The details of
these acquisitions are as set out in the table below:
Original No. of Current % of Company's
Shareholding Ordinary Shareholding Issued Share
Shares Capital
Acquired
Geoffrey 800,000 60,000 860,000 0.61%
Vernon
Don Evans 642,680 57,320 700,000 0.49%
Mary Tavener 101,562 10,000 111,562 0.08%
Stephen Harris 197,857 40,000 237,857 0.17%
Chris Meredith 0 15,000 15,000 0.01%
For further information, please contact:
Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com
Buchanan Communications Tel: +44 (0) 20 7466 5000
Mark Court, Mary-Jane Johnson
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.